Sari la conținut
  • 0756 100 387
  • Str. C. Brâncoveanu 11, Cluj-Napoca
  • Luni-Vineri: 09-17
  • Programează-te!
  • Acasă
  • Despre noi
  • Servicii
  • Afecțiuni
    • Cataractă
    • Cataractă secundară​
    • Miopia
    • Astigmatism
    • Strabismul​
    • Glaucom
    • Hipermetropia​
    • Neuropatie optică​
    • Retinopatie diabetică​
    • Uveita​
    • Degenerescența maculară​
    • Ambliopia
    • Astigmatism
  • Prețuri
  • Contact
Meniu
  • Acasă
  • Despre noi
  • Servicii
  • Afecțiuni
    • Cataractă
    • Cataractă secundară​
    • Miopia
    • Astigmatism
    • Strabismul​
    • Glaucom
    • Hipermetropia​
    • Neuropatie optică​
    • Retinopatie diabetică​
    • Uveita​
    • Degenerescența maculară​
    • Ambliopia
    • Astigmatism
  • Prețuri
  • Contact

Arhive: Publicatii

Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France

Comment on: „Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study”

Comments to: Long-term efficacy and safety of intravitreal dexamethasone implant for the treatment of diabetic macular edema

Correspondence – Comment on: „Central retinal vein occlusion: modifying current treatment protocols”

Pro-permeability Factors in Diabetic Macular Edema; The Diabetic Macular Edema Treated With Ozurdex Trial

Correspondence – Comment on: „Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab”

Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up (BERVOLT study: bevacizumab for RVO long-term follow-up)

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study

Correspondence – Comment on: „The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary”

Letter to the Editor: „Treat-and-Extend Intravitreal Bevacizumab for Branch Retinal Vein Occlusion”

← mai vechi
mai noi →
Examinări Oftalmologice - Tratamente - Operații Oftalmologice - Optică Medicala - Cristaline Artificiale
  • 0756 100 387
  • ocucentercluj@gmail.com
  • ANPC
  • 0756 100 387
  • info@ocucenter.ro
  • Str. Constantin Brâncoveanu 11, Cluj-Napoca
  • Lu-Vi: 9-17
  • Str. Constantin Brâncoveanu 11, Cluj-Napoca
  • Lu-Vi: 9-17
  • Politica de confidențialitate
  • Politica de cookies
  • Politica de confidențialitate
  • Politica de cookies
  • Politica de confidențialitate
  • Politica de cookies
  • Politica de confidențialitate
  • Politica de cookies
Solutionarea Alternativa a Litigiilor Solutionarea Online a Litigiilor
OcuCenter - Clinică de Oftalmologie - Optică Medicală 2023

WhatsApp